NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)
(1) Basis of Presentation
The accompanying unaudited condensed consolidated financial statements of CIRCOR International, Inc. (“CIRCOR” or the “Company”) have been prepared according to the rules and regulations of the United States (“U.S.”) Securities and Exchange Commission (“SEC”) for interim reporting, along with accounting principles generally accepted in the U.S. (“GAAP”). The unaudited condensed consolidated financial statements reflect all adjustments (consisting only of normal and recurring items) necessary for a fair presentation of the Company’s results of operations, financial position and cash flows for the periods presented. The Company prepares its interim financial information using the same accounting principles it uses for its annual audited consolidated financial statements. Certain information and note disclosures normally included in the annual audited consolidated financial statements have been condensed or omitted in accordance with SEC rules. The Company believes that the disclosures made in its unaudited condensed consolidated financial statements and the accompanying notes are adequate to make the information presented not misleading. The unaudited results of operations for interim periods reported are not necessarily indicative of the results for the full year or any other period.
The condensed consolidated balance sheet as of December 31, 2022 was derived from CIRCOR’s audited consolidated financial statements as of that date but does not include all of the information and notes required for annual financial statements. The Company recommends that the financial statements included in this Quarterly Report on Form 10-Q be read in conjunction with the consolidated financial statements and notes included in its Annual Report on Form 10-K for the year ended December 31, 2022 ("2022 Annual Report").
CIRCOR operates and reports financial information using a fiscal year ending December 31. The data periods contained within its Quarterly Reports on Form 10-Q reflect the results of operations for the 13-week, 26-week and 39-week periods which generally end on the Sunday nearest to the calendar quarter-end date. Operating results for the three months ended April 2, 2023 are not necessarily indicative of the results that may be expected for the year ending December 31, 2023 or any future period.
Unless otherwise indicated, all financial information and statistical data included in these notes to the Company's condensed consolidated financial statements relate to its continuing operations, with dollar amounts expressed in thousands (except share and per-share data).
(2) Summary of Significant Accounting Policies
The significant accounting policies used in preparation of these condensed consolidated financial statements for the three months ended April 2, 2023 are consistent with those discussed in Note 2 to the consolidated financial statements in the 2022 Annual Report.
The preparation of these financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying disclosures. Some of the more significant estimates, which are impacted by management's estimates and assumptions regarding the effects of the COVID-19 pandemic, relate to recoverability of goodwill and indefinite-lived trade names, estimated total costs for ongoing long-term revenue contracts where transfer of control occurs over time, inventory valuation, share-based compensation, amortization and impairment of long-lived assets, income taxes (including valuation allowance), fair value of disposal group, pension benefit obligations, acquisition accounting, penalty accruals for late shipments, asset valuations, and product warranties. While management believes that the estimates and assumptions used in the preparation of the financial statements are appropriate, actual results could differ materially from those estimates.
The Company has signed a supplier funding agreement with a customer. Under the terms of the agreement, the Company will receive funding up to $6.7 million in agreed milestones and in exchange for the funding received, the Company is required to purchase specified equipment to support manufacturing capacity and prioritize delivery of certain pump components.
During the quarter ended April 2, 2023, the Company received its first milestone payment of $2.4 million and purchased $1.5 million in equipment and machinery. The Company recorded the milestone payment as a reduction of the cost basis of the purchased equipment, with the $0.9 million funds remaining uncommitted and recorded as a deposit liability within "Accrued expenses and other current liabilities" on the condensed consolidated balance sheet as of April 2, 2023.
(3) Revenue Recognition
The Company's revenue is derived from a variety of contracts. A significant portion of revenues are from contracts associated with the design, development, manufacture or modification of highly engineered, complex and severe environment products with customers who are either in or service the aerospace, defense and industrial markets. Contracts within the defense markets are primarily with U.S. military customers. These contracts typically are subject to the Federal Acquisition Regulations. The Company accounts for a contract when it has approval and commitment from both parties, the rights of the parties are identified, payment terms are identified, the contract has commercial substance and collectability of consideration is probable. Contracts may be modified to account for changes in contract specifications and requirements.
For revenue that is recognized from products and services transferred to customers over time, the Company uses an input measure (e.g., costs incurred to date relative to total estimated costs at completion, known as the “cost-to-cost” method) to measure progress. The Company uses the cost-to-cost measure of progress because it best depicts the transfer of control to the customer which occurs as it incurs costs on its contracts. Under the cost-to-cost measure of progress, revenue is recognized proportionally as costs are incurred. Contract costs include labor, materials and subcontractors’ costs, other direct costs and an allocation of overhead, as appropriate.
As of April 2, 2023, the Company had $236.1 million of transaction price related to remaining performance obligations which, is invoiced and paid in accordance with terms of contractual agreements. The Company expects to recognize approximately 55% of its remaining performance obligations as revenue during the remainder of 2023, 35% in 2024, and the remaining 10% in 2025 and thereafter.
In order to determine revenue recognized during the period from contract liabilities at the beginning of the period, the Company first allocates revenue to the individual contract liabilities balance outstanding at the beginning of the period until the revenue exceeds that balance. If additional advances are received on those contracts in the subsequent periods, it assumes all revenue recognized in the reporting period first applies to the beginning contract liability as opposed to a portion applying to the new advances for the period. Revenue recognized during the three months ended April 2, 2023 that was included in contract liabilities at the beginning of the period amounted to $8.9 million.
Disaggregation of Revenue
The following tables present revenue disaggregated by major product line and geographical market (in thousands):
| | | | | | | | | | | | | | | | | | |
| Three Months Ended | | |
| April 2, 2023 | | April 3, 2022 | | | | |
| | | | | | | | |
| | | | | | | | |
Aerospace & Defense Segment | | | | | | | |
| Commercial Aerospace & Other | $ | 32,257 | | | $ | 25,214 | | | | | |
| Defense | 36,294 | | | 38,156 | | | | | |
| Total | 68,551 | | | 63,370 | | | | | |
Industrial Segment | | | | | | | |
| Valves | 43,957 | | | 45,477 | | | | | |
| Pumps | 90,589 | | | 76,808 | | | | | |
| Total | 134,546 | | | 122,285 | | | | | |
Net Revenues | $ | 203,097 | | | $ | 185,655 | | | | | |
| | | | | | | | | | | | | | | | | | | | | | |
| Three Months Ended | | | | |
| April 2, 2023 | | April 3, 2022 | | | | | | | | |
| | | | | | | | | | | | |
| | | | | | | | | | | | |
Aerospace & Defense Segment | | | | | | | | | | | |
| EMEA | $ | 17,926 | | | $ | 14,209 | | | | | | | | | |
| North America | 45,164 | | | 45,197 | | | | | | | | | |
| Other | 5,461 | | | 3,964 | | | | | | | | | |
| Total | 68,551 | | | 63,370 | | | | | | | | | |
Industrial Segment | | | | | | | | | | | |
| EMEA | 59,641 | | | 54,642 | | | | | | | | | |
| North America | 42,310 | | | 40,837 | | | | | | | | | |
| Other | 32,595 | | | 26,806 | | | | | | | | | |
| Total | 134,546 | | | 122,285 | | | | | | | | | |
| | | | | | | | | | | | |
Net Revenues | $ | 203,097 | | | $ | 185,655 | | | | | | | | | |
| | | | | | | | | | | | |
Contract Balances
The Company’s contract assets and contract liabilities balances as of April 2, 2023 and December 31, 2022 are as follows (in thousands):
| | | | | | | | | | | | | | | | | |
| |
| April 2, 2023 | | December 31, 2022 | | Increase/(Decrease) |
| | | | | |
Contract assets: | | | | | |
Recorded within prepaid expenses and other current assets | $ | 95,339 | | | $ | 98,406 | | | $ | (3,067) | |
Recorded within other assets | 8,121 | | | 7,677 | | | 444 | |
| $ | 103,460 | | | $ | 106,083 | | | $ | (2,623) | |
| | | | | |
Contract liabilities: | | | | | |
Recorded within accrued expenses and other current liabilities | $ | 37,625 | | | $ | 36,871 | | | $ | 754 | |
Recorded within other non-current liabilities | 3,747 | | | 5,149 | | | (1,402) | |
| $ | 41,372 | | | $ | 42,020 | | | $ | (648) | |
| | | | | |
Contract assets decreased by $2.6 million during the three months ended April 2, 2023, primarily due to invoicing upon completion of milestones in excess of revenue recognized within the Defense and Refinery Valves businesses partially offset by revenue recognized in excess of invoicing within the Industrial Valves business.
Contract liabilities decreased by $0.6 million during the three months ended April 2, 2023, primarily due to customer advances received in excess of revenue recognized in the Industrial Pumps and Refinery Valves businesses, partially offset by recognition of revenue against customer advances within the Defense business.
Revenue on over time contracts is recognized as the Company, in accordance with the terms of the applicable contract, transfers control in the underlying products or services to the customer, which occurs as it incurs costs on its contracts under the cost-to-cost measure of progress. Revenue on over time contracts may be recognized before or after payments, advances or progress billings from customers are received. The recognition of revenue on over time contracts before the Company can invoice the customer may result in contract assets. Receipt of progress billings or advances from customers in advance of recognizing revenue can result in contract liabilities. The contract assets and contract liabilities amounts presented above are determined at the contract level unit of account. At the contract level, it is determined whether the contract is in a net contract asset or net contract liability position.
Contract assets are generally classified between current (one year or less) and non-current (more than one year) based on factors such as when payments are due. Contract liabilities are generally classified as current or non-current based on factors such as the expected timing of performance obligation satisfaction.
Allowance for Credit Losses
The Company continuously monitors collections and payments from its customers and maintains a provision for estimated credit losses or doubtful accounts based upon expected losses, historical experience, expectation of changes in risk of loss and any specific customer collection issues that have been identified. During the three months ended April 2, 2023, there were no material changes in the allowance for credit losses including additional allowances, write-offs or recoveries. During the three months ended April 3, 2022, there were no material changes in the allowance for credit losses including additional allowances, write-offs or recoveries other than charges in the amount of $1.0 million for the Pipeline Engineering business as described further in Note 4, Special and Restructuring Charges (Recoveries), net.
(4) Special and Restructuring Charges (Recoveries), Net
Special and restructuring charges (recoveries), net
Special and restructuring charges (recoveries), net consist of restructuring costs (including costs to exit a product line or program) and certain special charges (recoveries) such as significant litigation settlements and other transactions (charges or recoveries) that are described below. All items described below are recorded in Special and restructuring charges (recoveries), net on the condensed consolidated statements of operations. Certain other special and restructuring charges (recoveries) such as inventory related items may be recorded in cost of revenues given the nature of the item.
The table below summarizes the amounts recorded within the special and restructuring charges (recoveries), net line item on the condensed consolidated statements of operations for the three months ended April 2, 2023 and April 3, 2022 (in thousands):
| | | | | | | | | | | | | | | |
| Special & restructuring charges (recoveries), net |
| Three Months Ended | | |
| April 2, 2023 | | April 3, 2022 | | | | |
Special charges, net | $ | 1,700 | | | $ | 2,556 | | | | | |
Restructuring (recoveries) charges, net | (216) | | | 6,447 | | | | | |
Total special and restructuring charges, net | $ | 1,484 | | | $ | 9,003 | | | | | |
Special charges (recoveries), net
The table below details the special charges (recoveries), net, recognized for the three months ended April 2, 2023 and April 3, 2022 (in thousands): | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Special charges (recoveries), net | |
| | Three Months Ended April 3, 2023 | |
| | Aerospace & Defense | | Industrial | | Corporate | |
Total | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
Strategic alternatives evaluation | | — | | | — | | | 1,250 | | | 1,250 | | |
| | | | | | | | | |
Other special charges, net | | — | | | 384 | | | 66 | | | 450 | | |
Total special charges, net | | $ | — | | | $ | 384 | | | 1,316 | | | 1,700 | | |
| | |
| | Special charges (recoveries), net | |
| | Three Months Ended April 3, 2022 | |
| | Aerospace & Defense | | Industrial | | Corporate | |
Total | |
Pipeline Engineering investigation and restatement costs | | $ | — | | | $ | — | | | $ | 1,341 | | | $ | 1,341 | | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
Other special charges | | — | | | 136 | | | 1,079 | | | 1,215 | | |
Total special charges, net | | $ | — | | | $ | 136 | | | 2,420 | | | 2,556 | | |
Strategic alternative evaluations costs: During the three months ended April 2, 2023, the Company recognized special charges of $1.3 million related to the evaluation of strategic alternatives for the Company.
Pipeline Engineering investigation costs: During the three months ended April 3, 2022, the Company recognized special charges of $1.3 million related to the investigation into accounting irregularities at the Company's Pipeline Engineering businesses.
Other special charges: During the three months ended April 3, 2022, the special charges, net, include a $0.9 million charge for severance related to the Company's former CEO comprised of $1.7 million in severance, partially offset by the accounting effects of forfeitures for certain unvested CEO stock-based compensation awards.
Restructuring charges (recoveries), net
The tables below detail the charges associated with restructuring actions recorded for the three months ended April 2, 2023 and April 3, 2022. Accruals associated with the restructuring actions are recorded within "Accrued expenses and other current liabilities" on the condensed consolidated balance sheets (in thousands):
| | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Restructuring charges (recoveries), net |
| | Three Months Ended April 2, 2023 |
| | Aerospace & Defense | | Industrial | | Corporate | |
Total |
Facility and other related charges (recoveries), net | | $ | 3 | | | $ | (219) | | | $ | — | | | $ | (216) | |
| | | | | | | | |
Total restructuring charges (recoveries), net | | $ | 3 | | | $ | (219) | | | $ | — | | | $ | (216) | |
| | | | | | | | |
Accrued restructuring charges as of December 31, 2022 | | | | | | | | $ | 837 | |
Total charges, net (shown above) | | | | | | | | (216) | |
Charges paid / settled, net | | | | | | | | (297) | |
Accrued restructuring charges as of April 2, 2023 | | | | | | | | $ | 324 | |
| | | | | | | | |
| | Restructuring charges (recoveries), net |
| | Three Months Ended April 3, 2022 |
| | Aerospace & Defense | | Industrial | | Corporate | |
Total |
Facility and other related charges (recoveries), net | | $ | — | | | $ | 5,432 | | | $ | — | | | $ | 5,432 | |
Employee related expenses, net | | — | | | 722 | | | 293 | | | 1,015 | |
Total restructuring charges (recoveries), net | | $ | — | | | $ | 6,154 | | | $ | 293 | | | $ | 6,447 | |
| | | | | | | | |
Accrued restructuring charges as of December 31, 2021 | | | | | | | | $ | 1,839 | |
Total charges, net (shown above) | | | | | | | | 6,447 | |
Charges paid/settled, written-off, net | | | | | | | | (6,335) | |
Accrued restructuring charges as of April 3, 2022 | | | | | | | | $ | 1,951 | |
The Company recorded a restructuring recovery of $0.2 million during the three months ended April 2, 2023, in Industrial related to the termination of a leased building of the former Pipeline Engineering business.
The Company recorded restructuring charges of $6.4 million during the three months ended April 3, 2022, of which $5.9 million related to the exit of the Pipeline Engineering business. The $5.9 million charge consists of $5.3 million in impairments, $0.6 million of termination benefits. Impairments of $5.3 million included $3.8 million related to the write downs of Property, Plant and Equipment, Right of Use Assets and Intangibles, which is a level three fair value measurement based on the expected cash proceeds from disposition of the assets. In addition, the Company recorded $1.5 million in charges for write downs of working capital accounts, including primarily $1.0 million for accounts receivable. Included in the Industrial employee related expenses is $0.6 million in severance and termination benefits related to the exit of the Pipeline Engineering business.
In addition, during the three months ended April 3, 2022, the Company recorded a charge of $2.8 million for write down of inventories related to the exit of the Pipeline Engineering business classified within cost of revenues on the condensed consolidated statements of operations.
During the same period, the Company recorded $0.3 million of employee related charges, not associated with the exit of the Pipeline Engineering business.
(5) Inventories
Inventories consisted of the following as of April 2, 2023 and December 31, 2022 (in thousands):
| | | | | | | | | | | |
| April 2, 2023 | | December 31, 2022 |
Raw materials | $ | 65,539 | | | $ | 59,431 | |
Work in process | 73,110 | | | 63,846 | |
Finished goods | 18,318 | | | 16,509 | |
Total inventories | $ | 156,967 | | | $ | 139,786 | |
(6) Goodwill and Intangibles, Net
The following table shows the movement in goodwill by segment from December 31, 2022 to April 2, 2023 (in thousands):
| | | | | | | | | | | | | | | | | | | | | |
| | Aerospace & Defense | | Industrial | | | Total |
Goodwill as of December 31, 2022 | | $ | 57,381 | | | $ | 62,466 | | | | $ | 119,847 | |
| | | | | | | |
Currency translation adjustments | | 18 | | | 249 | | | | 267 | |
Goodwill as of April 2, 2023 | | $ | 57,399 | | | $ | 62,715 | | | | $ | 120,114 | |
|
The Company performs an impairment assessment for goodwill at the reporting-unit level and for its indefinite-life intangible assets on an annual basis during the fourth quarter, or more frequently if circumstances warrant. At April 2, 2023, the Company determined there were no indicators of impairment requiring interim assessment.
The table below presents gross intangible assets and the related accumulated amortization as of April 2, 2023 (in thousands):
| | | | | | | | | | | | | | | | | |
| April 2, 2023 |
| Gross Carrying Amount | | Accumulated Amortization | | Net Carrying Value |
Patents | $ | 5,368 | | | $ | (5,368) | | | $ | — | |
Customer relationships | 287,134 | | | (157,299) | | | 129,835 | |
Acquired technology | 133,073 | | | (85,809) | | | 47,264 | |
| | | | | |
Total Amortized Intangibles | $ | 425,575 | | | $ | (248,476) | | | $ | 177,099 | |
| | | | | |
Non-amortized intangibles (trademarks and trade names) | $ | 72,280 | | | $ | — | | | $ | 72,280 | |
| | | | | |
Net carrying value of intangible assets | | | | | $ | 249,379 | |
| | | | | |
| |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
Amortization of intangible assets was $7.9 million and $9.4 million for the three months ended April 2, 2023 and April 3, 2022, respectively.
The table below presents estimated remaining annual amortization expense for intangible assets recorded as of April 2, 2023 (in thousands):
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| 2023 | | 2024 | | 2025 | | 2026 | | 2027 | | After 2027 | | |
Estimated amortization expense | $ | 23,186 | | | $ | 27,609 | | | $ | 24,101 | | | $ | 20,962 | | | $ | 16,779 | | | $ | 64,462 | | | |
(7) Segment Information
The Company's Chief Operating Decision Maker (the “CODM”) evaluates segment operating performance using segment operating income. Segment operating income is defined as GAAP operating income excluding intangible amortization and amortization of fair value step-ups of inventory and fixed assets from acquisitions completed subsequent to December 31, 2011, the impact of restructuring related inventory write-offs, impairment charges and special charges or gains. The Company also refers to this measure as adjusted operating income. The Company uses this measure because it helps management understand and evaluate the segments’ core operating results and serves as the basis for determining incentive compensation achievement.
The following table presents certain reportable segment information (in thousands):
| | | | | | | | | | | | | | | |
| Three Months Ended | | |
| April 2, 2023 | | April 3, 2022 | | | | |
Net revenues | | | | | | | |
Aerospace & Defense | $ | 68,551 | | | $ | 63,370 | | | | | |
Industrial | 134,546 | | | 122,285 | | | | | |
Net revenues | $ | 203,097 | | | $ | 185,655 | | | | | |
| | | | | | | |
Results from continuing operations before income taxes | | | | | | | |
Aerospace & Defense - Segment Operating Income | $ | 14,714 | | | $ | 11,320 | | | | | |
Industrial - Segment Operating Income | 20,402 | | | 6,857 | | | | | |
Corporate expenses | (6,743) | | | (7,770) | | | | | |
Subtotal | 28,373 | | | 10,407 | | | | | |
Special charges, net | 1,700 | | | 2,556 | | | | | |
Restructuring (recoveries) charges, net | (216) | | | 6,447 | | | | | |
Special and restructuring charges, net | 1,484 | | | 9,003 | | | | | |
Restructuring related inventory charges | — | | | 2,757 | | | | | |
| | | | | | | |
Acquisition amortization | 7,920 | | | 9,391 | | | | | |
Acquisition depreciation | 1,053 | | | 1,045 | | | | | |
Restructuring, impairment and other costs, net | 8,973 | | | 13,193 | | | | | |
Consolidated operating income (loss) | 17,916 | | | (11,789) | | | | | |
Interest expense, net | 14,528 | | | 9,456 | | | | | |
Other expense (income), net | 214 | | | (1,287) | | | | | |
| | | | | | | |
Income (loss) before income taxes | $ | 3,174 | | | $ | (19,958) | | | | | |
| | | | | | | |
| | | | | | | |
| Three Months Ended | | |
| April 2, 2023 | | April 3, 2022 | | | | |
Capital expenditures | | | | | | | |
Aerospace & Defense | $ | 1,178 | | | $ | 1,286 | | | | | |
Industrial | 3,947 | | | 1,663 | | | | | |
Corporate | 168 | | | 352 | | | | | |
Consolidated capital expenditures | $ | 5,293 | | | $ | 3,301 | | | | | |
| | | | | | | |
Depreciation and amortization | | | | | | | |
Aerospace & Defense | $ | 2,241 | | | $ | 2,521 | | | | | |
Industrial | 10,177 | | | 11,706 | | | | | |
Corporate | 219 | | | 170 | | | | | |
Consolidated depreciation and amortization | $ | 12,637 | | | $ | 14,397 | | | | | |
| | | | | | | |
Identifiable assets | April 2, 2023 | | December 31, 2022 | | | | |
Aerospace & Defense | $ | 564,845 | | | $ | 557,018 | | | | | |
Industrial | 1,265,337 | | | 1,261,996 | | | | | |
Corporate | (814,453) | | | (806,327) | | | | | |
| | | | | | | |
Consolidated identifiable assets | $ | 1,015,729 | | | $ | 1,012,687 | | | | | |
The total assets for each reportable segment have been reported as the Identifiable Assets for that segment, including inter-segment intercompany receivables, payables and investments in other CIRCOR subsidiaries. Identifiable assets reported in Corporate include both corporate assets, such as cash, deferred taxes, prepaid and other assets, and fixed assets, as well as the elimination of all inter-segment intercompany assets. The elimination of intercompany assets results in negative amounts reported in Corporate for Identifiable Assets.
(8) Financing Arrangements
Fair Value
The Company utilizes fair value measurement guidance prescribed by accounting standards to value its financial instruments. The guidance establishes a fair value hierarchy based on the inputs used to measure fair value. This hierarchy prioritizes the inputs into three broad levels as follows:
•Level One: Inputs to the valuation methodology are unadjusted quoted prices for identical assets or liabilities in active markets.
•Level Two: Inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets or liabilities in inactive markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument.
•Level Three: Inputs to the valuation methodology are unobservable and significant to the fair value measurement.
A financial instrument’s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement.
The carrying amounts of cash and cash equivalents, restricted cash, trade receivables and trade payables approximate fair value because of the short term maturity of these financial instruments. Cash equivalents are carried at cost which approximates fair value at the balance sheet date and is a Level 1 financial instrument. As of April 2, 2023, the estimated fair value of the Company's gross debt (before netting debt issuance costs) was $515.7 million, compared to carrying cost of $519.6 million. At December 31, 2022, the estimated fair value of the Company’s gross debt (before netting debt issuance costs) was $502.7 million, compared to carrying cost of $516.9 million. The Company’s outstanding debt balances are characterized as Level 2 financial instruments.
Financial Instruments
As of April 2, 2023 and December 31, 2022, the Company had restricted cash balances of $1.9 million and $2.4 million, respectively. These balances are recorded within prepaid expenses and other current assets on the condensed consolidated balance sheets, and are included within cash, cash equivalents and restricted cash in the condensed consolidated statements of cash flows.
The Company has a receivable purchasing agreement with a bank whereby the Company can sell selected accounts receivable and obtain 90% of the purchase price upfront, net of applicable discount fee, and obtain the residual amount as the receivables are collected. During the three months ended April 2, 2023, the Company sold a total of $11.0 million of receivables under the program, receiving $9.9 million in upfront cash. During the three months ended April 3, 2022, the Company sold a total of $14.1 million of receivables under the program, receiving $12.7 million in upfront cash. At April 2, 2023 and April 3, 2022, a beneficial interest balance of $1.1 million and $1.4 million, respectively, was recorded in prepaid expenses and other current assets on the condensed consolidated balance sheet.
Effective April 2018, the Company entered into an interest rate swap agreement pursuant to an ISDA Master Agreement with Citizens Bank, National Association. The four-year interest rate swap had a fixed notional value of $400.0 million with a 1% LIBOR floor and matured on April 12, 2022. The interest rate swap was a qualifying hedging instrument and was accounted for as a cash flow hedge pursuant to Accounting Standards Codification ("ASC") 815, Derivatives and Hedging. The interest rate swap was settled upon its maturity during the second quarter of 2022.
The amount of gains (loss) recognized in other comprehensive income (loss), net of tax (“OCI”) and reclassified from accumulated other comprehensive loss (“AOCI”) to earnings are summarized below (in thousands):
| | | | | | | | | | | | | | | | |
| | | | | Three Months Ended | | | Three Months Ended |
| | | | | April 2, 2023 | | | April 3, 2022 |
Amount of (loss) recognized in OCI | | | | | $ | — | | | | $ | (9) | |
| | | | | | | | |
Amount of (loss) reclassified from AOCI to earnings (interest expense, net of tax) | | | | | $ | — | | | | $ | (1,702) | |
Interest expense, net (including the effects of the cash flow hedges) related to the portion of the Company's term loan subject to the aforementioned interest-rate swap agreement was $6.9 million for the three months ended April 3, 2022.
Debt
As of April 2, 2023, total debt (including short-term borrowings and current portion of long-term debt) was $500.0 million compared to $496.5 million as of December 31, 2022. Total debt is net of unamortized term loan debt issuance costs of $19.6 million and $20.4 million at April 2, 2023 and December 31, 2022, respectively. The Company made interest payments of $13.6 million and $8.9 million during the three months ended April 2, 2023, and April 3, 2022, respectively.
In April 2022, the Company entered into Amendment No. 1 to the Credit Agreement (the “First Amendment”). The First Amendment makes certain changes to the Original Credit Agreement, including (i) extending the deadline for the Company to deliver its annual financial statements for the fiscal year ended December 31, 2021, (ii) increasing the interest rate margins for (a) the term loan facility to 5.50% with respect to Eurodollar loans, (b) the revolving facility to 4.75% with respect to Eurodollar loans and (c) the swing line facility to 3.75%, (iii) in the event of a step-down in the debt ratings of the facilities, increasing the interest rate margins for the term loan facility by an additional 0.50% during any such step-down period, (iv) decreasing certain debt, lien, investment, restricted payment and affiliate transaction baskets and negative covenant thresholds by 15%, (v) further decreasing or eliminating the use of certain debt, lien, investment and restricted payment baskets during the period until the date on which the Company delivers the annual financial statements for the fiscal year ended December 31, 2021 (such period, the “Restricted Period”), (vi) eliminating the minimum threshold and reinvestment rights with respect to mandatory prepayments of the term loans with the net cash proceeds of sale-leaseback transactions, subject to certain exceptions, (vii) restricting the Company’s ability to borrow swing loans or revolving loans if the aggregate amount of cash and cash equivalents of the Company and its domestic subsidiaries exceeds $10.0 million and creating a requirement to prepay outstanding swing loans and revolving loans with any such excess, in each case, during the Restricted Period, (viii) resetting the “soft call” prepayment premium for an additional 12 months, and (ix) requiring the Company to hold private-side lender calls twice upon request of the Administrative Agent during the Restricted Period and promptly after the delivery of all quarterly and annual financial statements. In connection with the execution of the First Amendment, the Company paid approximately $12.5 million in customary arranger and lender consent fees, attorney fees, and reasonable and documented expenses of the Administrative Agent.
In May 2022, the Company entered into Amendment No. 2 to the Credit Agreement (the “Second Amendment”). The Second Amendment made certain changes to the Credit Agreement, including, extending the deadline for the Company to deliver its annual financial statements for the fiscal year ended December 31, 2021 and its quarterly financial statements for the fiscal quarters ended April 3, 2022 and July 3, 2022. In addition, the Company is required to hold private-side lender calls at least once per month upon request, and promptly after the delivery of all quarterly and annual financial statements. In connection with the execution of the Second Amendment, the Company paid approximately $4.2 million in customary arranger and lender consent fees, attorney fees, and reasonable and documented expenses of the Administrative Agent.
Prior to Amendments No.1 and No. 2, the Company had $12.6 million of unamortized debt discount and debt issuance costs associated with its term loan and $1.5 million unamortized deferred financing fees associated with its revolver as of April 3, 2022. Per Amendments No. 1 and No. 2, the Company incurred an additional $15.5 million of debt discount and issuance costs associated with the term loan and $1.2 million of fees associated with the revolver. The Company evaluated the accounting for this transaction under ASC 470 to determine modification versus extinguishment accounting on a creditor-by-creditor basis. During the second quarter of 2022, the Company accounted for a combination of old and new debt discount and issuance costs totaling $23.1 million as a modification (recorded as a debt discount and issuance costs on the consolidated balance sheet) and accounted for $5.0 million as a debt extinguishment (included in special charges on the consolidated statements of operations). For the revolving credit facility, $1.2 million was rolled into the existing Credit Agreement (included in other assets) during the second quarter of 2022 based on the borrowing capacity with the underlying banks.
(9) Guarantees and Indemnification Obligations
As permitted under Delaware law, the Company has agreements whereby it indemnifies certain of its officers and directors for certain events or occurrences while the officer or director is, or was, serving at its request in such capacity. The term of the indemnification period is for the officer’s or director’s lifetime. The maximum potential amount of future payments the Company could be required to make under these indemnification agreements is unlimited. However, the Company has directors’ and officers’ liability insurance policies that insure it with respect to certain events covered under the policies and should enable it to recover a portion of any future amounts paid under the indemnification agreements. The Company has no liabilities recorded from those agreements as of April 2, 2023.
The Company records provisions for the estimated cost of product warranties, primarily from historical information, at the time product revenue is recognized. The Company also records provisions with respect to any significant individual warranty issues as they arise. Although, the Company engages in extensive product quality programs and processes, its warranty obligation is affected by product failure rates, utilization levels, material usage, service delivery costs incurred in correcting a product failure, and supplier warranties on parts delivered to the Company. Should actual product failure rates, utilization levels, material usage, service delivery costs or supplier warranties on parts differ from the Company’s estimates, revisions to the estimated warranty liability would be required.
The following table sets forth information related to product warranty reserves for the three months ended April 2, 2023 and April 3, 2022 (in thousands):
| | | | | | | | | | | | | | | |
| Three Months Ended | | |
| April 2, 2023 | | April 3, 2022 | | | | |
| | | | | | | |
Balance beginning | $ | 2,521 | | | $ | 2,739 | | | | | |
Provisions | 583 | | | 451 | | | | | |
Claims settled | (669) | | | (644) | | | | | |
| | | | | | | |
Currency translation adjustment | 12 | | | (20) | | | | | |
Balance ending | $ | 2,447 | | | $ | 2,526 | | | | | |
Warranty obligations are recorded within Accrued expenses and other current liabilities on the condensed consolidated balance sheets.
(10) Commitments and Contingencies
The Company is subject to various legal proceedings and claims pertaining to matters such as product liability or contract disputes. The Company is also subject to other proceedings and governmental inquiries, inspections, audits or investigations pertaining to issues such as tax matters, patents and trademarks, pricing, contractual issues, business practices, governmental regulations, employment and other matters. Although the results of litigation and claims cannot be predicted with certainty, the Company expects that the ultimate disposition of these matters, to the extent not previously provided for, will not have a material adverse effect, individually or in the aggregate, on its business, financial condition, results of operations or liquidity.
Asbestos-related product liability claims continue to be filed against two of the Company's subsidiaries: CIRCOR Instrumentation Technologies, Inc. (f/k/a Hoke, Inc.) (“Hoke”), the stock of which the Company acquired in 1998, and Spence Engineering Company, Inc., the stock of which the Company acquired in 1984. The Hoke subsidiary was divested in January 2020 through the sale of the I&S business. However, the Company has indemnified the buyer for asbestos-related claims that are made against Hoke. Due to the nature of the products supplied by these entities, the markets they serve and the Company's historical experience in resolving these claims, the Company does not expect that these asbestos-related claims will have a material adverse effect on the financial condition, results of operations or liquidity of the Company.
During the second quarter of 2021, the Company was notified of a contract termination by one of its Industrial segment customers. The basis for termination is under dispute and the ultimate outcome of this matter is uncertain. During the fourth quarter of 2021, the Company recorded a full allowance against the outstanding receivables resulting in a charge of $6.3 million. The Company also has outstanding guarantees of its performance under the contract in the aggregate amount of $3.4 million. Further, the Company is exposed to claims from sub-contractors for contract termination. During the fourth quarter of 2022, a settlement agreement was reached resulting in a total of $4.5 million to be paid in the first half of 2023. The Company has accrued the unpaid portion of the settlement amount as of April 2, 2023.
Standby Letters of Credit
The Company executes standby letters of credit, which include bid bonds and performance bonds, in the normal course of business to ensure performance or payments to third parties. The aggregate notional value of these instruments at April 2, 2023 was $32.0 million of which $25.8 million was syndicated under the Credit Agreement. This compares with aggregate notional value of $32.4 million of which $24.4 million was syndicated under the Credit Agreement as of December 31, 2022. These instruments generally have expiration dates ranging from less than one month to five years from April 2, 2023.
During May 2022, a Russian customer drew on a letter of credit related to an equipment system in the amount of $3.9 million, which the Company funded. The Company is contesting the draw and is pursuing actions to recover this amount from the customer.
(11) Retirement Plans
The following table sets forth the components of total net periodic benefit (income) cost of the Company’s defined benefit pension plans and other post-retirement employee benefit plans (in thousands):
| | | | | | | | | | | | | | | |
| Three Months Ended | | |
| April 2, 2023 | | April 3, 2022 | | | | |
Pension Benefits - U.S. Plans | | | | | | | |
Interest cost | $ | 1,917 | | | $ | 1,000 | | | | | |
Expected return on plan assets | (2,104) | | | (2,150) | | | | | |
| | | | | | | |
Amortization | 36 | | | 48 | | | | | |
Net periodic benefit income | $ | (151) | | | $ | (1,102) | | | | | |
| | | | | | | |
Pension Benefits - Non-U.S. Plans | | | | | | | |
Service cost | $ | 323 | | | $ | 621 | | | | | |
Interest cost | 828 | | | 366 | | | | | |
Expected return on plan assets | (184) | | | (203) | | | | | |
Amortization | (340) | | | — | | | | | |
Net periodic benefit cost | $ | 627 | | | $ | 784 | | | | | |
| | | | | | | |
Other Post-Retirement Benefits | | | | | | | |
Service cost | $ | 1 | | | $ | 1 | | | | | |
Interest cost | 84 | | | 53 | | | | | |
| | | | | | | |
Net actuarial (gain) loss | (85) | | | — | | | | | |
Net periodic benefit cost | $ | — | | | $ | 54 | | | | | |
| | | | |
|
|
The periodic benefit service costs are included in both costs of revenues, and in selling, general, and administrative expenses, while the remaining net periodic benefit costs are included in other expense (income), net in the condensed consolidated statements of operations for the three months ended April 2, 2023 and April 3, 2022.
The Company did not make any employer contributions to the Company’s U.S. or non-U.S. based defined benefit pension plans during the three months ended April 2, 2023 and April 3, 2022.
(12) Income Taxes
The provision for income taxes to income (loss) is as follows (in thousands):
| | | | | | | | | | | | | | | | | | | | | |
| | Three Months Ended | | | |
| | April 2, 2023 | | April 3, 2022 | | | | | |
Income (loss) before income taxes | | $ | 3,174 | | | $ | (19,958) | | | | | | |
Effective tax rate | | 112.8 | % | | (7.6) | % | | | | | |
Provision for income taxes | | $ | 3,581 | | | $ | 1,523 | | | | | | |
The Company is required to compute income tax expense in each jurisdiction in which it operates. This process requires the Company to project its current tax liability and estimate its deferred tax assets and liabilities, including net operating loss (“NOL”) and tax credit carryforwards. In assessing the ability to realize the net deferred tax assets, the Company considers whether it is more likely than not that some portion or all of the net deferred tax assets will not be realized.
The effective tax rate for the three months ended April 2, 2023, differed from the U.S. federal statutory rate of 21% primarily due to adjustments to the domestic and foreign valuation allowances, and the earnings in foreign jurisdictions combined with unbenefited U.S. losses. The effective tax rate for the three months ended April 3, 2022, differed from the U.S. federal statutory rate primarily due to adjustments to the domestic and foreign valuation allowances and adjustments related to uncertain tax positions. The Company has a full valuation allowance in the U.S. and Germany, and intends to continue maintaining valuation allowances on these deferred tax assets until there is sufficient evidence to support the release of all or some portion of these allowances.
As of April 2, 2023 and December 31, 2022, the Company had $1.3 million and $1.5 million, respectively, of unrecognized tax benefits including penalty and interest, all of which would affect the Company's effective tax rate if recognized in any future period.
(13) Share-Based Compensation
As of April 2, 2023, the Company had 26,184 stock options, 537,297 Restricted Stock Unit Awards (“RSU Awards”) and Restricted Stock Unit Management Stock Plan Awards (“RSU MSPs”) outstanding. The Company's 2019 Stock Option and Incentive Plan (the “2019 Plan”) authorizes the issuance of up to 2,000,000 shares of common stock (subject to adjustment for stock splits and similar events). Under the 2019 Plan, there were 1,035,579 shares available for grant as of April 2, 2023.
During the three months ended April 2, 2023 and April 3, 2022, there were no stock options granted.
For additional information regarding the historical issuance of stock options, refer to Note 13, Share-Based Compensation to the consolidated financial statements included in the 2022 Annual Report.
During the three months ended April 2, 2023 and April 3, 2022, the Company granted 197,908 and 1,009 RSU Awards with approximate fair values of $32.00 and $26.60 per RSU Award, respectively. Due to the delay in filing of the 2021 Annual Report, the grant of annual equity awards in 2022, which typically takes place during the first quarter of each fiscal year, was postponed until August 2022. During the three months ended April 2, 2023, the Company granted 46,078 performance-based RSU Awards, compared to 0 performance-based RSU Awards granted during the three months ended April 3, 2022. The performance-based RSU Awards granted in 2023 include a market condition based on the Company's total shareholder return relative to a subset of the S&P 600 SmallCap Industrial Companies over a three-year performance period. The target payout range for these performance-based awards is 0% to 200% with a cap not to exceed 600% of the target value on the grant date. These performance-based RSUs were valued using a Monte Carlo Simulation model to account for the market condition on grant date.
There were 37,020 RSU MSPs granted during the three months ended April 2, 2023 with a per unit discount of $10.20, compared to 0 RSU MSPs granted during the three months ended April 3, 2022.
Compensation expense related to the Company’s share-based plans for the three months ended April 2, 2023 and April 3, 2022 was $1.0 million and $(0.1) million, respectively. The significant increase in compensation cost in the three months ended April 2, 2023 compared with the same prior-year period relates primarily to forfeitures associated with the departure of the Company's former CEO in January 2022 as well as the delay in granting annual equity awards in 2022. Compensation expense for the three months ended April 2, 2023 was recorded entirely in selling, general and administrative expenses. Compensation expense for the three months ended April 3, 2022 was recorded as follows: $0.5 million in selling, general and administrative expenses and $(0.6) million in special charges (recoveries), net. Special charges (recoveries), net relate to forfeitures associated with the departure of the Company's former CEO, partially offset by certain equity vesting accelerations for the Company's former CEO and other Corporate staff whose positions were eliminated. As of April 2, 2023, there were $10.9 million of total unrecognized compensation costs related to the Company’s outstanding share-based compensation arrangements. That cost is expected to be recognized over a weighted average period of 2.3 years.
The weighted average contractual term for stock options outstanding and exercisable as of April 2, 2023 was 1.8 years.
The aggregate intrinsic value of RSU Awards settled during the three months ended April 2, 2023 was $1.2 million and the aggregate intrinsic value of RSU Awards outstanding as of April 2, 2023 was $14.9 million.
(14) Accumulated Other Comprehensive Loss
The following table summarizes the changes in accumulated other comprehensive loss, net of tax, which is reported as a component of shareholders’ equity, for the three months ended April 2, 2023 and April 3, 2022 (in thousands):
| | | | | | | | | | | | | | | | | | | | | | | |
| Foreign Currency Translation Adjustments | | Pension, net | | Derivative | | Total |
Balance as of December 31, 2022 | (66,887) | | | 22,778 | | | — | | | $ | (44,109) | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
Other comprehensive (loss) income | 2,065 | | | (49) | | | — | | | 2,016 | |
Balance as of April 2, 2023 | $ | (64,822) | | | $ | 22,729 | | | $ | — | | | $ | (42,093) | |
| | | | | | | |
Balance as of December 31, 2021 | $ | (54,432) | | | $ | 4,944 | | | $ | 688 | | | $ | (48,800) | |
Other comprehensive (loss) income | (3,075) | | | 51 | | | 1,693 | | | (1,331) | |
Balance as of April 3, 2022 | $ | (57,507) | | | $ | 4,995 | | | $ | 2,381 | | | $ | (50,131) | |
| | | | | | | |
| | | | | | | |
(15) Income (Loss) Per Common Share (“EPS”)
| | | | | | | | | | | | | | | |
| Three Months Ended | | |
| April 2, 2023 | | April 3, 2022 | | | | |
Basic weighted average shares outstanding | 20,368 | | | 20,310 | | | | | |
Effect of dilutive securities (1) | — | | | — | | | | | |
Dilutive weighted average shares outstanding | 20,368 | | | 20,310 | | | | | |
| | | | | | | |
(1) Includes the effect of dilutive stock options, RSU Awards and RSU MSPs | | | | | | | |
For the three months ended April 2, 2023, there were 270,170 anti-dilutive stock options, RSU Awards, and RSU MSPs with exercise (grant) prices ranging from $30.91 to $60.99. For the three months ended April 3, 2022, there were 511,896 anti-dilutive stock options, RSU Awards and RSU MSPs with exercise (grant) prices ranging from $31.52 to $60.99.